mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.9 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |